Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Non-alcoholic Steatohepatitis
NCT04080947Phase 2Completed
- Sponsor
- Sadat City University
- Start
- Aug 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of montelukast in Nonalcoholic steatohepatitis (NASH), sponsored by Sadat City University. Started Aug 2019; status: completed.
02
Drugs
montelukast
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04080947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080947.